DyeVert System and Contrast-induced Acute Kidney Injury
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 522 participants.
Also called NCT04714736
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose prevention
- Phase
- Not applicable
- Enrolled
- 522 participants
- Sponsor
- Clinica Mediterranea
- Registry
-
NCT04714736
-
- Other papers using this trial's data
- Kidney Injury After Minimal Radiographic Contrast Administration in Patients With Acute Coronary Syndromes
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Italy
- Registry status
- Completed
Technical summary
Registry record NCT04714736. Randomized; single masking; primary purpose prevention. Start 2020-02-10 (actual); primary completion 2022-12-31 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- DyeVert System and Contrast-induced Acute Kidney Injury
- Acronym
- REMEDIALIV
- Condition
- Contrast-induced Acute Kidney Injury
- Condition
- Acute Coronary Syndromes
- Intervention (Device)
- Coronary angiography using DyeVert system
- Intervention (Procedure)
- Coronary angiography using conventional manual injection syringe.
- Lead sponsor
- Clinica Mediterranea
Record details
- Record id
cardio:ct-nct04714736- Content hash
01f212409a86703bf55396de493245f1b3ca9f61c0593c2eac4088f97065ed12